u/Better-Badger-7996

2 theses · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$IXHLr/pennystocksDDbullish
u/Better-Badger-7996 · 145d ago1 prior · awaiting results

$ixhl so heavy in here

Incannex is trading at deep discount to cash value ($75M cash, $38M market cap) with zero debt and active buyback. Two Phase 2 drugs (PSX-001 for anxiety at 83% efficacy with FDA Fast Track; IHL-42X for sleep apnea at 83% efficacy) face favorable policy tailwinds and represent separate billion-dollar markets. Low float from 1:30 reverse split creates explosive upside potential on volume return or acquisition by major pharma.

At post $3.91Now $2.38-39.1% since postedas of Nov 2, 4:15 PM ET
1d-2.3%
3d-2.0%
1w-5.4%
1m-13.3%
3m-13.8%
6m—
1y—
original post →
$IXHLr/pennystocksDDbullish
u/Better-Badger-7996 · 152d ago1 prior · awaiting results

$ixhl #ixhl yes ik the past is bad but cmon the facts are just to nice PLEASE READ!!!

Incannex is trading at half cash value with $75M cash and zero debt while conducting a $20M buyback. Two Phase 2 drugs (PSX-001 for anxiety and IHL-42X for sleep apnea, both showing 83% improvement) have FDA Fast Track designation and favorable policy tailwinds. The reverse split has created a tight float that could compress sharply once institutional attention returns or an acquisition materializes.

At post $3.06Now $2.38-22.2% since postedas of Nov 2, 4:15 PM ET
1d+1.0%
3d-4.6%
1w+27.8%
1m+29.7%
3m+3.9%
6m—
1y—
original post →

End of results.